Brain Computer Interface (BCI) Integrated Wearable Hand Robotic Glove System for Upper Limb Stroke Rehabilitation

September 2, 2025 updated by: Tan Tock Seng Hospital

Brain Computer Interface (BCI) Integrated Wearable Hand Robotic Glove System for Upper Limb Stroke Rehabilitation: A 3-arm Randomized Controlled Trial

Upper extremity (UE) recovery remains a huge rehabilitation challenge with largely incomplete recovery of the upper limb post stroke. This is due to heavier priorities placed on other stroke competencies such as mobility, activities of daily living training and home integration which results in suboptimal amounts of time spent in upper limb training post stroke.

In this study the investigators plan to pilot brain computer interface (BCI) integrated wearable hand robotic glove (HandyRehab) system for upper limb stroke rehabilitation.

Study Overview

Detailed Description

Robot-aided therapy have shown promising results in rehabilitation recovery in stroke patients while reducing strain and effort for both the therapist and suitable patients.

HandyRehab (HR) is a portable, wearable hand robotic glove used for functional training. The integration of Brain Computer Interface (BCI) platform with HR provides an alternative way of communication or intended movement through end-effectors for stroke and potentially facilitate neuroplasticity, improving motor functions.

This study aims to validate the usability of intensive training with HandyRehab (HR) compared with conventional occupational therapy (CT). Feasibility and safety of the novel BCI-HR will be examined and objective measures of clinical efficacy will be compared across all 3 platforms.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Age 21-85 years, males and females
  2. First diagnosis of stroke (ischemic or haemorrhagic), confirmed by neurologist/neurosurgeon/CT/MRI imaging
  3. > 16 weeks post stroke
  4. Hemiplegic pattern of post-stroke weakness
  5. MRC ≥ 2/5 motor power and above for shoulder abduction & elbow flexion
  6. MRC 0 to 4/5 motor power and above for finger flexors &/or extensors of thumb, index, middle fingers
  7. Screening Fugl-Meyer wrist hand sub score <18/24
  8. Spasticity MAS <3 for thumb, index, and middle fingers
  9. Able to discriminate thumb and index sensation to pain
  10. Hand sizes within 170-200mm (length) &75-85mm (width), compatible with HandyRehab robotic glove
  11. BCI compatible brain states using a standardised screening protocol
  12. Able to understand simple commands with Mini Mental state examination scores MMSE > 21/30)
  13. Able to give informed consent

    • Subjects who are unable to clear BCI screening 11. will be randomised to either CT or HR groups.

Exclusion Criteria:

Neurological

  • Recurrent stroke
  • Diagnosis of neurodegenerative disease; e.g. Parkinson's' disease, Dementia, ALS

Medical:

- unstable medical or neurological conditions, life expectancy <6 months, end-organ renal failure on dialysis, severe heart failure, postural hypotension, history of uncontrolled sepsis, epilepsy with seizure within 3 months of informed consent, skin conditions which could potentially be worsened by wearable robot (ulcers, open wounds, eczema, infections etc)

Postural:

  • Unable to tolerate upright posture or sit unaided for < 90min with rest breaks
  • Cognitive/behavioural/visual:
  • Severe dysphasia/aphasia, severe visual neglect/blindness, untreated severe depression, psychiatric illness, unable to understand study requirements

Upper limb:

  • Moderate to severe spasticity (Modified Ashworth scale MAS ≥2)
  • Hand/arm related pain (VAS Pain ≥ 5/10),
  • Presence of finger contractures, reduced functional range of motion, limiting functional wrist/finger movements, active fractures or arthritis with deformities
  • Severe limb ataxia/apraxia
  • Severe post stroke hemi-anaesthesia in affected UE

BCI incompatibility:

  • Motor imagery EEG signals unable to be detected
  • Presence of craniectomy skull defect (affecting BCI cap fit and electrode contact)
  • Concomitant participation in other interventional research trials
  • Resident of nursing home or overseas country which may compromise attendance at research site
  • Pregnant or lactating females will not be allowed to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: Conventional supervised occupational therapy (CT)
CT consists of standard occupational therapy for hand function which includes but not limited to the following treatment (1) passive and active mobilisation; (2) spasticity management; (3) training with use of various modalities/equipment; (4) gross and fine motor training including reach and grasp/release functions, and object manipulation; (5) grasp training: cylindrical, spherical, intrinsic, 2-finger pincer and 3-finger grip.
Standard Conventional Occupational Therapy
Active Comparator: HandyRehab (HR) with supervised training by OT
HR training consists of (1) passive and active mobilisation (2) spasticity management (3) gross motor training with HR applied (4) grasp training: cylindrical, spherical, intrinsic, 2-finger pincer and 3-finger grip.
Standard Conventional Occupational Therapy
A wearable hand robotic glove approved by Health Sciences Authority, class I commercial device
Experimental: HandyRehab integrated with BCI (BCI-HR) with supervised training by OT
BCI-HR training consists of (1) passive and active mobilisation (2) spasticity management (3) gross motor training with BCI-HR applied (4) grasp training: cylindrical, spherical, intrinsic, 2-finger pincer and 3-finger grip.
Standard Conventional Occupational Therapy
To test the usability, safety and efficacy of an experimental prototype of a wearable hand robotic glove integrated with brain computer interface system being developed and researched.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Action Research Arm Test (ARAT) Score
Time Frame: Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)
Functional and dexterity score in the affected arm evaluated using 19 tests of motor function across 4 subsets; minimum score = 0, maximum score = 57, with higher score indicating better function.
Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fugl-Meyer Motor Assessment (FMA) scale
Time Frame: Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)
Change in Fugl Meyer Motor Assessment score in the affected arm, minimum: 0, maximum: 66 with higher scores indicating greater levels of mobility function
Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)
Grip Strength (kg)
Time Frame: Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)
Measured by Digital hand-held Dynamometer (mean of 3 readings) for both hands
Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)
Box and Block Test (BBT)
Time Frame: Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)
Measures unilateral gross manual dexterity.
Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)
Nine Hole Peg Test (NHPT)
Time Frame: Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)
Measures finger dexterity in stroke patients.
Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)
Self-efficacy outcomes by UPSET (upper limb self-efficacy test)
Time Frame: Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)
Questionnaire to measure self-efficacy in various tasks after stroke.
Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)
Hr-QOL scales using SS-QOL (Stroke specific Quality of Life scale)
Time Frame: Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)
Quality of life scale specific to stroke patients, minimum 49, maximum 245; with higher scores indicating better function.
Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)
Patient reported Outcome Measures (PROMs) using subjective scales (Likert 0-5)
Time Frame: Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)
Measures patient's opinion on the usability of HR and BCI-HR
Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)
Montreal Cognitive Assessment (MOCA)
Time Frame: Weeks 0 (baseline), 6 (end training), 24, 52 (follow-up)
Screening assessment to determine cognitive impairment.
Weeks 0 (baseline), 6 (end training), 24, 52 (follow-up)
Rey Auditory Verbal Learning Test (RAVLT)
Time Frame: Weeks 0 (baseline), 6 (end training), 24, 52 (follow-up)
Cognitive assessment to evaluate verbal learning and memory
Weeks 0 (baseline), 6 (end training), 24, 52 (follow-up)
Trail Making Test (TMT)
Time Frame: Weeks 0 (baseline), 6 (end training), 24, 52 (follow-up)
Neuropsychological test assessing visual attention and task switching.
Weeks 0 (baseline), 6 (end training), 24, 52 (follow-up)
Digit Span
Time Frame: Weeks 0 (baseline), 6 (end training), 24, 52 (follow-up)
Cognitive Assessment of both forward and backward variants.
Weeks 0 (baseline), 6 (end training), 24, 52 (follow-up)
Controlled Oral Word Association Test (COWAT)
Time Frame: Weeks 0 (baseline), 6 (end training), 24, 52 (follow-up)
Neuropsychological measure of verbal fluency.
Weeks 0 (baseline), 6 (end training), 24, 52 (follow-up)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Ashworth Scale (MAS)
Time Frame: Weeks 0 (baseline), 6 (end training), 24, 52 (follow-up)
Measures the level of spasticity at the elbow and finger flexors of proximal interphalangeal joint regions; scored from "0 to 4" with "4" indicating affected part is more spastic in flexion/extension.
Weeks 0 (baseline), 6 (end training), 24, 52 (follow-up)
Visual Analogue Scale (self-reported pain score)
Time Frame: Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)
Unidimensional measure of pain intensity; "0" being no pain and "10" being worst pain.
Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Karen Chua, Tan Tock Seng Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2024

Primary Completion (Estimated)

January 1, 2026

Study Completion (Estimated)

January 1, 2026

Study Registration Dates

First Submitted

September 20, 2023

First Submitted That Met QC Criteria

October 4, 2023

First Posted (Actual)

October 11, 2023

Study Record Updates

Last Update Posted (Estimated)

September 9, 2025

Last Update Submitted That Met QC Criteria

September 2, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Standard Treatment of Care

Subscribe